Speaker Profile
M.D., Ph.D., Neurology, MIT
Biography
Diane Chan, MD, Ph.D. (MGH/MIT). Diane is a new Assistant in Neurology at MGH. She earned her M.D.- Ph.D. degrees at Boston University with a focus on Parkinson’s disease for her Ph.D. research. She completed her medical training in Neurology at Yale New Haven Hospital where she was the recipient of the Gilbert Glaser Award and a R25 NINDS Research Fellowship from the NIH. She completed a fellowship at MGH and Brigham and Women’s Hospital in 2019. She is now seeing patients in the FTD Unit in Memory Disorders and Comprehensive Neurology at the Massachusetts General Hospital while concurrently conducting post-doctoral research at MIT in Li-Huei Tsai’s laboratory to translate two different non-invasive brain stimulation technologies for the potential treatment of Alzheimer’s disease and Parkinson’s disease into human use. She is currently matriculated in the Harvard Catalyst Clinical and Translational Research Academy at Harvard Medical School.
Session Abstract – PMWC 2027 Silicon Valley
Track Chair:
David Liebeskind, UCLA
PMWC Award Ceremony
• Li-Huei Tsai, MIT Picower Institute (Pioneer)
• Thomas C. Südhof, Stanford (Nobel Laureate, Pioneer)
• David Holtzman, WashU (Pioneer)
• Henrik Zetterberg, UCL / Gothenburg (Luminary)
Featured Speakers
• Thomas C. Südhof, Stanford
• Li-Huei Tsai, MIT Picower Institute
• David Holtzman, WashU
• Henrik Zetterberg, UCL / Gothenburg
• Mark Mintun, Lilly
• Randall Bateman, WashU
• Nikolaos Mellios, Circular Genomics
• Robert Rissman, USC
• Lynn Kramer, Eisai
• Thomas F. Tropea, University of Pennsylvania
• Ari J. Green, UCSF
• Diane Chan, Mass General Brigham
• Leslie Shaw, University of Pennsylvania
• Prashanthi Vemuri, Mayo Clinic
• Kejal Kantarci, Mayo Clinic
• Dan Huddleston, Lightbox Science
• Patrick Brannelly, 10K Brains
• Allan Levey, Emory
From Blood Test to Treatment
Are we finally diagnosing Alzheimer's early enough to change care?
Precision Diagnostics Across Neurology
From biomarker to bedside across neurological disease.
Neurodegeneration Beyond Alzheimer's
Parkinson's, ALS, and FTD in the precision era.
AI & Imaging Across Neurological Disease
Precision phenotyping in stroke, epilepsy, and neurodegeneration.
Why Precision Neurology Is Not Scaling
The evidence, infrastructure, access, and workflow barriers that must be fixed.
Harnessing Brain Rhythms
Gamma oscillations, brain circuits, and the future of neurotherapy.
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
